Roseburg philanthropists Cheryl and Allyn Ford donate $16 million to establish a comprehensive clinic for children with pediatric neuromuscular disorders. Erika Finanger, M.D., says, “For years I have dreamed of a one-stop clinic where kids and their families can access all the right people and services in one place and in one day. Thanks to this incredibly generous gift, that dream will soon come true.”

Peptomyc announces the approval of a Research Investigational New Drug (IND) application for a new clinical trial in collaboration with the OHSU Knight Cancer Institute and the OHSU Brenden-Colson Center for Pancreatic Care to evaluate OMO-103 in patients with a form of pancreatic cancer. Charlie Lopez, M.D., Ph.D., says, “We are excited to collaborate with Peptomyc on this important trial. By conducting this study, we hope to gain valuable insights that will ultimately lead to improved outcomes for cancer patients.”

Immunovia announces the completion of a promising study to detect early-stage pancreatic ductal adenocarcinoma. Rosalie Sears, M.D., says, “This study validates the high accuracy of the Immunovia test in detecting stage 1 and 2 pancreatic cancer in a challenging high-risk population.”

Immunovia announces the completion of a promising study to detect early-stage pancreatic ductal adenocarcinoma. Rosalie Sears, M.D., says, “This study validates the high accuracy of the Immunovia test in detecting stage 1 and 2 pancreatic cancer in a challenging high-risk population.”

In a perspective published by HealthIT Answers, William Hersh, M.D., writes that he will redefine his longstanding introductory course in biomedical informatics to make artificial intelligence explicitly more prominent. He writes, “To this end, I am changing the name of the course, which will now be called Introduction to Biomedical Informatics and Artificial Intelligence.”

In a series of video interviews taken at the 2024 American Society of Hematology annual meeting, Curtis Lachowiez, M.D., discusses the influence of AML differentiation state on outcomes of patients treated with frontline hypomethylating agents plus venetoclax.

The American Journal of Managed Care reports on an OHSU study presented during the American Society of Hematology that found mental health challenges, financial pressures and not having a caregiver at home are among the reasons patients delay allogeneic hematopoietic cell transplantation when diagnosed with acute myeloid leukemia.

The Oregonian republishes an Albany Democrat-Herald story about a Lebanon couple, married for 60 years, managing dementia. The story references the couple meeting with a specialist at OHSU and quotes Michael LaMantia, M.D., chief of geriatrics and palliative care at the Portland VA Health Care System.

An OHSU-led study reveals a potential compound found in dahlias could be useful in treating certain forms of cancer and neurodegenerative conditions. The study is a collaboration between the lab of Larry Sherman, Ph.D., and the University of Portland’s Angela Hoffman, Ph.D., whose students screened compounds from various flowers and plants. Sherman says, “The more I learn about nature, the more I appreciate nature. What else could be out there that would be the next great discovery?”

KGW-TV covers an OHSU-led study that reveals a potential compound found in dahlias could be useful in treating certain forms of cancer and neurodegenerative conditions. The study is a collaboration between the lab of Larry Sherman, Ph.D., and the University of Portland’s Angela Hoffman, Ph.D., whose students screened compounds from various flowers and plants. Sherman says, “The more I learn about nature, the more I appreciate nature. What else could be out there that would be the next great discovery?”